---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-037733"
form_type: "8-K/A"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-08-13T20:01:17+00:00"
generated_at: "2026-08-13T20:02:09.244338+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DNA X sells final Series B Preferred for $2.5M; pro forma equity $5.84M exceeds Nasdaq minimum

## Summary
- On Aug 7, 2026, sold 416,667 Series B Preferred shares for $2.5M cash.
- Pro forma stockholders' equity at Aug 7: $5.84M, above Nasdaq's $2.5M requirement.
- Q1 2026 actual net income $6.34M; Q2 2026 est. net loss $1.53M; Aug 7 est. net loss $639k.
- Adjustments include $4.946M financing, $3.049M note conversion, $963k reclass of redeemable shares.
- Awaiting Nasdaq formal determination of compliance with Listing Rule 5550(b)(1).

## SEC filing metadata
- accession: 0001493152-26-037733
- form_type: 8-K/A
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-08-13T20:01:17+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226037733/0001493152-26-037733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226037733/form8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-037733
- JSON: https://secwatch.observer/filing/0001493152-26-037733.json
- Plain text: https://secwatch.observer/filing/0001493152-26-037733.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.